Related Experiment Videos
[Infectious mononucleosis]
1Clinical Laboratory Center, The University of Tokyo Hospital, Bunkyo-ku, Tokyo 113-8655.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|January 5, 2002
Summary
Infectious mononucleosis (IM) is a primary Epstein-Barr virus (EBV) infection. Immune system activation, including CD8+ and CD4+ T lymphocytes, helps ensure IM has a benign course.
Area of Science:
- Immunology
- Virology
- Cell Biology
Context:
- Infectious mononucleosis (IM) is a primary Epstein-Barr virus (EBV) infection.
- EBV is known to cause lymphoid cell line proliferation and malignant diseases, but IM is typically self-limiting.
- EBV antibodies are crucial for diagnosing IM, especially in cases negative for heterophil antibodies.
Purpose:
- To investigate the immune response in patients with infectious mononucleosis.
- To identify specific immune cell subsets activated during primary EBV infection.
Summary:
- The study observed activated CD8+ lymphocytes expressing HLA-DR and CD45RO, increased intracellular pH, and elevated sCD8 plasma levels in IM patients.
- Activation of CD4+ T lymphocytes and gamma delta T lymphocytes was also demonstrated.
- These findings indicate a robust immune response to EBV during IM.
Impact:
- The activation of T lymphocyte subsets is hypothesized to play a key role in the typically benign course of infectious mononucleosis.
- Understanding these immune mechanisms may offer insights into managing EBV-related conditions.